Catalyst
Slingshot members are tracking this event:
Takeda's (TKPYY) Ninlaro in Multiple Myeloma Recommended for Approval by European Ad Comm
- Source Link:
- https://www.takeda.com/news/2016/20160916_7564.html
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
TKPYY |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Ninlaro, European Medicines Agency, Chmp, Multiple Myeloma